{"name":"Infinity Pharmaceuticals, Inc.","slug":"infinity-pharmaceuticals-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Placebo plus Docetaxel","genericName":"Placebo plus Docetaxel","slug":"placebo-plus-docetaxel","indication":"Metastatic breast cancer","status":"marketed"}]}],"pipeline":[{"name":"Placebo plus Docetaxel","genericName":"Placebo plus Docetaxel","slug":"placebo-plus-docetaxel","phase":"marketed","mechanism":"Docetaxel is a microtubule-stabilizing chemotherapy agent that disrupts cell division, combined with placebo as a control comparator.","indications":["Metastatic breast cancer","Non-small cell lung cancer","Prostate cancer","Gastric cancer","Head and neck cancer"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPUTBGcWFMQnY3ZTM2ODdOUkt0VWNJTG5KanJuekZoZU1FeUx5RlNJWGQ3OUphTXJxVEVqZVNPcGZ0aktYc0FpYjc3U2VfUzNjY2IwLUdZb2ZZeDhoOWJ5eUVSWmlXT1FwbTdjQmdwOU12b0dZbk5zcjIyM3BQYmU4R2FmWmQ1LWY0ZWF0WjFPd1RzUDl4blIwWDlmYktYSzRPZ3RHWUJFS1dDNWJCMHJUZC03UVl1V3hDYWlsSWlxSUM?oc=5","date":"2026-04-07","type":"pipeline","source":"AFR","summary":"Lenders warned major Priceline franchisee of risks well before failure - AFR","headline":"Lenders warned major Priceline franchisee of risks well before failure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAJBVV95cUxOa3M0UlRnRDJDclo5c0lDYXd0MVNTSkpTZmNOUkl3MDEyZEk4anRzallJSzBfb2R0a28wRnFoVWYyM2tNVVEyS0tVNWczY1RXSWl0Q0JQeVZBNmRZNzJYZk5FRC16cUFvQWxXV0tSaXJfUE8xTElyRDc0SXJ4QkppY3JINVpQVURrM2dJcnVjVjdGQnp6M3NyUmctXzczbTVDNk5pbEhSeWQzelBTQ2dyb3VwZG8tbWtIV1JJUTg1aURZM0d6VXo3YzNrNm03a2IxazFDQ2JqSm0yNWVXU1dySnpKUG5iekFyalFYNDl2TE5sZXRBSWt5aDQyZFhaOUx0cXRvYk5JbXI5bmVGU1JsTkhmU2ZNbjJxNFNIVE1JUndiQ2g4aXZHaXVMSE1acjFDQVFXYThTOWFJNjBtWlZHQVVGRG5lWHJQcERaRQ?oc=5","date":"2026-03-31","type":"trial","source":"Barchart.com","summary":"Urothelial Carcinoma Clinical Trial Pipeline Expands as 40+ Pharma Companies Progress 50+ Novel Therapies Toward Market Entry, Finds DelveInsight | Janssen Research and Development, MedPacto - Barchar","headline":"Urothelial Carcinoma Clinical Trial Pipeline Expands as 40+ Pharma Companies Progress 50+ Novel Therapies Toward Market ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxPWFU2RUg3bUpYQ2hQTTlodHlURURKVlN3SzhiTTR4UUpHdEgyVl9KQmpJQTBJanNjVHlpSzdsbS02MjJBa2xuVGloc0FfMUNKMUJ6UnBBT2tURVhNVFMyT3BEclo1Y3NvVXhwSTA5VThuVkpfVmY5d0tyWC1QUGt5dGQ5Szc2NlNqVHo4Y2RGbkVvZ0tDdXhKakQtanZ1RWtPa0h3RHM3MzFrMUJWTGNGSldlMWR0ZnRseHc?oc=5","date":"2026-02-15","type":"pipeline","source":"WSYX","summary":"Columbus police investigate car crash into Infinity Pharmacy on Westerville Road - WSYX","headline":"Columbus police investigate car crash into Infinity Pharmacy on Westerville Road","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxNMm4ycFY0NmM4N0w3UGtlTlpUMlpKV201N081blEzSXpsT3RBa3VqU28xM1Z4ZWFSejhUdVB3eHNPbFVRdEFwSzJrekdiS2xSUVpPYWNBSUhkUUU3QWc5X3F3LVBhOWp4WkRibGR6VEdvRTdOVUFBUXNjRDhydHV3NEl0ZlA4R2RWVEgtbFZPV1p1SV9yRmpGYUlyeFU4QS1rd0VfWEhsQ2JqMmJZbWtuWG9XNGZkTzFDOWlBOQ?oc=5","date":"2026-01-20","type":"pipeline","source":"TechStock²","summary":"Wesfarmers walks away from a $400m Priceline rescue — and now the Infinity pharmacies are up for grabs - TechStock²","headline":"Wesfarmers walks away from a $400m Priceline rescue — and now the Infinity pharmacies are up for grabs - TechStock²","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxOdG55eC1XejU0UWpKZ1ZlYWtScFhmelhENzhXWWprZEE4Nks5NEw1V3ZrSV9GVVN5dVBrbG9ONk54ODVJNHRVbHhrN24tTmNlSFpmSkFQU0NsUENGMV9wWTNZY1lvWWFhQ2tfRmpVM2pZUXloMzNqbWdHVjdOU25aRmNiYjdIa0JqbzNOZ004ZV9xZzdHWm1EVV9VRnBDYkotdlZNNUlwazBFemgyWGNIY1NnWUpVUnEwUURsdEVGb3VrRDRjNFlWNTZ6a3FYdmIyMWctMm0xeElxNTMyNG5FV2IxRQ?oc=5","date":"2026-01-18","type":"pipeline","source":"Yahoo Finance Australia","summary":"Fresh twist after Wesfarmers puts Priceline stores at risk as 54 pharmacies placed into receivership - Yahoo Finance Australia","headline":"Fresh twist after Wesfarmers puts Priceline stores at risk as 54 pharmacies placed into receivership","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxNM2V0VElQcHUtUGpnSl9rcF9NSXRTNURjclVVa2VSZ0dnM2ZJNzU5WFViSHpmaTU1SjViakQteFR2Q1ZjSFNMY2JKWENkcDY3UmtnMWFUR2VEenNzaFltUEctaFdHOXJpQl92VHc4WG0xS1oya2JVTm9PN0twUE9Nd25CLVpXeS1WZVhkV0tYS1gtUFNPS1NGODI5OEROS25xcnJZV3B3?oc=5","date":"2025-08-12","type":"trial","source":"BioWorld News","summary":"Fosun out-licenses phase II DPP-1 to newco Expedition for $645M - BioWorld News","headline":"Fosun out-licenses phase II DPP-1 to newco Expedition for $645M","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQNWF3SXZOdk1RTVZYNERRTWl5dkxIYmt2OHdMNkRUQk9Eczc5ZnhRYW1SSmd0OTJ1X011UEt5cF9YOWlGc2Frbkhxd2JtQTBKTGpHd01FUG05RkE0Vk9OUWZzNnBRUktmSm5NZGM5NW1vRVo2SG50a3RnV1NEOG1lSFVEWTlvUllUT3NEV1BVN2dUeUtJQU9uVXlIbTE4eUNNcEl5bkZ0TE1VOFNLSG1zWHY1cUk?oc=5","date":"2025-08-05","type":"pipeline","source":"San Diego Business Journal","summary":"MEI Pharma Invests in Litecoin as Primary Treasury Asset - San Diego Business Journal","headline":"MEI Pharma Invests in Litecoin as Primary Treasury Asset","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNT3VMSlRXc282ZDRIRjlQTzlqNlQ4dTFZVW5pVW5JRkFBTko0NERnRGtodml2VUE3ak9EcUZhdm1teGlOWDVYelM4a1FzRE1odzZsSVU4TWVKblp1TVNQR2xqR2VSOEpRbktWVmF0eFNGUzdEQkN1dmFQTnlvbTVjRjZBVjZjMjYwWjU5UDc1d0dUZGtGSy0tdDg2dkx6MmkwT05iQXBCQQ?oc=5","date":"2025-05-15","type":"pipeline","source":"WISN","summary":"'It broke my heart': Milwaukee-area pharmacies targeted in burglaries - WISN","headline":"'It broke my heart': Milwaukee-area pharmacies targeted in burglaries","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijgFBVV95cUxOWDQwVXN4ekxuZmR2VVJXR3RZaWRUS0RsbUZqc2lsSWJsc2oyNmhKa21pa2g3dDdNV2RGT3Z3ZXloV19mQXhNOTJwZFpSY01hdm9hMHlONGV1RHRCUlZDelRBYmo5ZUNqM2NJRDBrUTItc0lIdVEzX3F1anlhLVNGX1AzQVcySnNNR2tFVG5R?oc=5","date":"2023-10-02","type":"pipeline","source":"Fierce Biotech","summary":"Infinity comes to an end with Chapter 11 bankruptcy filing - Fierce Biotech","headline":"Infinity comes to an end with Chapter 11 bankruptcy filing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQU2M2NHMtaE9qZU9EdTRtU1dmbVRfc1g5Si03LVlsVlFZTXdsdmJLeGRqTVhadjRadGFmYmZaaXh4WVdaMXV3cm94dVN4TEhlWGs2Zl9aMWl4WjFmVlk1clBxMTllZEJBRDZZVlBrMkd0Q2ZELU5nN1FsNjZWTmltcl9yNlE2MVI3WVZSVGNOeURWdlM4QlFoalBuaE5Gd1Q3SUROenJibDNtckxkQ0F1VW9zazBtQk0?oc=5","date":"2023-09-05","type":"deal","source":"The Business Journals","summary":"Three execs leave Infinity Pharmaceuticals after failed merger, layoffs - The Business Journals","headline":"Three execs leave Infinity Pharmaceuticals after failed merger, layoffs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQNjRPbThXTkRWZmV2NV81emVPNjRicElxZ29OTzhKbWxTLUM5c0Y1TFRKRHhKMkJiOVBpeHR2MUFGNGRKN2JJZlBDZ2p6c0JCZG1CYm84dk10WEg5a3Q2c0FrQWlHZC11cUF2NkMyX28xUW9OTGp4NGIwQXlzcmZfdEc5OVd6b1d2X2oxVQ?oc=5","date":"2023-07-26","type":"deal","source":"BioPharma Dive","summary":"Infinity to lay off staff, offload cancer drug after merger falls apart - BioPharma Dive","headline":"Infinity to lay off staff, offload cancer drug after merger falls apart","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxOS292RkV5aU5DdlEwUWZ4RFhCX0NydzhlV3FKVXR1OFJmTFJrZ1B0cUluM3hGenFTQXpBMGNZLTlDVTJReU1DQU1LNzNpZDM4eUJIa1BFM2JDay1jbzJ5V2Z2QTJHOUpneVBlVXdnSnpvWkZIV0phUllNak41SHZPYWZTS2twbTUwZE9QTV90QlgzZXJtOWxXUFhJcWlxQ0IyS21lX0ZMSll1a25nVHBQQi00VUVTbktaMEl5bWZ2QQ?oc=5","date":"2023-03-28","type":"pipeline","source":"Business Wire","summary":"Infinity Pharmaceuticals Reports Full Year 2022 Financial Results - Business Wire","headline":"Infinity Pharmaceuticals Reports Full Year 2022 Financial Results","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}